, Volume 9, Issue 9, pp 563-570
Date: 21 Oct 2007

Peptidomimetics in cancer chemotherapy

Rent the article at a discount

Rent now

* Final gross prices may vary according to local VAT.

Get Access

Abstract

A summary of the current status of the application of peptidomimetics in cancer therapeutics as an alternative to peptide drugs is provided. Only compounds that are used in therapy or at least under clinical trials are discussed, using inhibitors of farnesyltransferase, proteasome and matrix metalloproteinases as examples.

Supported by an unrestricted educational grant from Roche Farma S.A.